Skip to content

Return on equity at other companies

Abbott logo
AbbottABT
12.4%-18.4pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.5%+1.3pp
Danaher logo
DanaherDHR
7.1%-0.1pp
Revvity logo
RevvityRVTY
3.2%-0.5pp
Quest Diagnostics logo
Quest DiagnosticsDGX
14.3%+0.9pp
Opko Health logo
Opko HealthOPK
-16.9%-21.7pp

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

Based on trailing twelve months.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's return on equity?
QuidelOrtho Corporation (QDEL) reported return on equity of -49.9% in Q1 2026.
How has QuidelOrtho Corporation's return on equity changed year-over-year?
QuidelOrtho Corporation's return on equity decreased by 339.0% year-over-year, from -11.4% to -49.9%.
What is the long-term trend for QuidelOrtho Corporation's return on equity?
Over 4 years (2020 to 2025), QuidelOrtho Corporation's return on equity has grown at a -14.3% compound annual growth rate (CAGR), from 85.6% to -46.1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.